ECSP982510A - NEW COMPOUNDS - Google Patents

NEW COMPOUNDS

Info

Publication number
ECSP982510A
ECSP982510A ECSP982510A ECSP982510A EC SP982510 A ECSP982510 A EC SP982510A EC SP982510 A ECSP982510 A EC SP982510A EC SP982510 A ECSP982510 A EC SP982510A
Authority
EC
Ecuador
Prior art keywords
6alkyl
alkyl
optionally substituted
amino
group
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Giuseppe Arnaldo Maria Giardina
Luca Francesco Raveglia
Mario Grugni
Davide Graziani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982510 priority Critical patent/ECSP982510A/en
Publication of ECSP982510A publication Critical patent/ECSP982510A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto o un solvato o una sal del mismo de fórmula (I) (gráfico), en la que Ar es un grupo arilo o cicloalcadienilo C5-7 opcionalmente sustituido, o un grupo cicloalquilo C5-7 o un grupo heterocíclico aromático de anillo único o condensado opcionalmente sustituido; R es alquilo C1-6, cicloalquilo C3-7, cicloalquilo C3-7, alquilo, fenilo o fenil-alquilo C1-6 opcionalmente sustituido, un anillo heteroaromático de cinco miembros, opcionalmente sustituido, que comprende hasta cuatro heteroátmos seleccionados entre O y N, hidroxi-alquilo C1-6, amino-alquilo C1-6-carbonilo, carboxi, alcoxi C1-6 carbonilo, alcoxi C1-6-carbonil-alquilo C1-6, aminocarbonilo, halógeno-alquilo C1-6; o R es un grupo -(CH2)p-en que P es 2 ó 3, cuyo grupo forma un anillo con un átomo de carbono de Ar. R1 representa hidrógeno o hasta cuatro sustituyentes opcionales seleccionados entre la lista que consta de; alquilo C1-6, alquenilo C1-6, arilo, alcoxi C1-6, hidroxi, halógeno, nitro, ciano, carboxi, carboxamido, sulfonamido, alcoxi C1-6-carbonilo, trifluorometido, aciloxi, oftalimido, amino o mono-y di-alquil C1-6-amino R2 representa un resto -(CH2)n -NY1 Y2 en que n es un número entero en el margen de 1 a 9, Y1 es Y2 se seleccionan independientemente entre hidrógeno, alquilo C1-6; alquilo C1-6 sustituido con hidroxi, alquil C1-6 amino o bis (alquil C1-6-amino; alquenilo C1-6; arilo o aril-alquilo C1-6 o Y1 e Y2 conjuntamente con el átomo de nitrógeno al que estan unidos, representan un grupo heterociclico simple o condensado enlazado en N y opcionalmente sustituído; R3 es alquilo C1-6 ramificado o lineal, cicloalquilo C3-7, ciclolaquilquilo C4-7, arilo opcionalmente sustituido, o un grupo heterocíclico aromático de anillo simple o condensado, opcionalmente sustituido, y R4 representa hidrógeno o alquilo C1-C6; una composición farmacéutica que comprende dicho compuesto, un procedimiento para preapra dicho compuesto y el uso de dicho compuesto en medicina.A compound or solvate or salt thereof of formula (I) (graph), wherein Ar is an optionally substituted C5-7 cycloalkadyl or aryl group, or a C5-7 cycloalkyl group or a single ring aromatic heterocyclic group or optionally substituted condensate; R is C 1-6 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl, optionally substituted alkyl, phenyl or phenyl-C 1-6 alkyl, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatoms selected from O and N , hydroxy-C1-6alkyl, amino-C1-6alkyl-carbonyl, carboxy, C1-6alkoxycarbonyl, C1-6alkoxy-carbonyl-C1-6alkyl, aminocarbonyl, halogen-C1-6alkyl; or R is a group - (CH2) p-in which P is 2 or 3, the group of which forms a ring with a carbon atom of Ar. R1 represents hydrogen or up to four optional substituents selected from the list consisting of; C 1-6 alkyl, C 1-6 alkenyl, aryl, C 1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulfonamido, C 1-6 alkoxy-carbonyl, trifluoromethido, acyloxy, ophthalimido, amino or mono-and di -C1-6alkyl-amino R2 represents a residue - (CH2) n -NY1 Y2 where n is an integer in the range of 1 to 9, Y1 is Y2 are independently selected from hydrogen, C1-6 alkyl; C1-6alkyl substituted with hydroxy, C1-6alkyl amino or bis (C1-6alkyl-amino; C1-6alkenyl; aryl or aryl-C1-6alkyl or Y1 and Y2 together with the nitrogen atom to which they are attached , represent an optionally substituted and N-linked fused or simple heterocyclic group; R3 is branched or linear C1-6 alkyl, C3-7 cycloalkyl, C4-7 cyclolakyl, optionally substituted or fused aromatic heterocyclic group, optionally substituted, and R4 represents hydrogen or C1-C6-alkyl, a pharmaceutical composition comprising said compound, a method for pre-preparing said compound and the use of said compound in medicine.

ECSP982510 1998-05-21 1998-05-21 NEW COMPOUNDS ECSP982510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982510 ECSP982510A (en) 1998-05-21 1998-05-21 NEW COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982510 ECSP982510A (en) 1998-05-21 1998-05-21 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
ECSP982510A true ECSP982510A (en) 1999-04-13

Family

ID=42043431

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982510 ECSP982510A (en) 1998-05-21 1998-05-21 NEW COMPOUNDS

Country Status (1)

Country Link
EC (1) ECSP982510A (en)

Similar Documents

Publication Publication Date Title
AR021354A1 (en) PROCEDURE FOR THE PREPARATION OF A QUINOLINE DERIVATIVE COMPOUND AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION
CO4950515A1 (en) NEW DERIVATIVES OF QUINOLINE FOR MEDICINAL USE
AR004735A1 (en) CHINOLEIN 4-AMIDO SUBSTITUTED, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
UY26727A1 (en) USEFUL TROPANIC DERIVATIVES IN THERAPY
AR038536A1 (en) N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES
CO5670367A2 (en) PHENOXYACETIC ACID DERIVATIVES
CL2012000999A1 (en) Substituted pyrazolospiroketone derivative compounds, acetyl-coa carboxylase inhibitors; pharmaceutical composition comprising them; use to treat or delay the progression or onset of type 2 diabetes, non-alcoholic fatty liver (hgna), or hepatic insulin resistance.
EA200200942A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES 3-AMINOAZETIDINE, NEW DERIVATIVES AND METHOD FOR THEIR PREPARATION
AR004706A1 (en) A COMPOUND DERIVED FROM BENZOXAZINE AND PIRIDO-OXAZINA USEFUL AS ANTIMICROBIALS, PHARMACEUTICAL COMPOSITION THAT CONTAIN IT, A METHOD TO PREPARE SUCH COMPOUNDS AND INTERMEDIARIES USEFUL FOR SUCH METHOD.
ATE380818T1 (en) PIPERAZINE-SUBSTITUTED ARYL-BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOSIS
ES2188957T3 (en) N- (4- (HETEROARILMETIL) FENIL) -HETEROARILAMINAS.
CO5011090A1 (en) DERIVATIVES OF ACIL-PIPERAZINIL-PIRIMIDINAS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
PE20040907A1 (en) ANILINOPYRAZOLE DERIVATIVES
AR027744A1 (en) USEFUL DIFENILIC ETER COMPOUNDS IN THERAPY
UY27803A1 (en) DERIVATIVES OF BENZOXAZINE AND USES OF THE SAME.
EA200300927A1 (en) A NEW METHOD OF INDUSTRIAL SYNTHESIS OF TETROSETTED ETHERS 5- [BIS (PHYCH) AND-3-TIOPHENCARBONIC ACID AND APPLICATION FOR THE SYNTHESIS OF BATHELETHYLETHYLETCHENKARBONOVOI ACID AND APPLICATION FOR SYNTHESIS
GB9825554D0 (en) Novel Compounds
PE20250849A1 (en) NOVEL 7-SUBSTITUTED INDOLE SULFONAMIDE DERIVATIVES
AR037459A1 (en) ANTAGONISTS VI OF THE CCR-3 RECEIVER
PY0435702A (en) FUNGICIDAL MIXTURES BASED ON CARBAMATE DERIVATIVES AND INSECTICIDES
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
CO5680413A2 (en) AMINO ACIDS WITH AFFINITY FOR C2 DELTA PROTEIN
AR015445A1 (en) METHOD FOR PREPARING A COMPOUND DERIVED FROM QUINOLINA, SUCH COMPOUNDS AND INTERMEDIATE COMPOUNDS
ECSP982510A (en) NEW COMPOUNDS
AR057464A1 (en) PROCEDURE FOR THE PREPARATION OF SULFONAMIDE DERIVATIVES